Future biosimilars for IL-17 and IL-23 inhibitors (e.g., Cosentyx, Skyrizi) could further expand the ... (which require hospital administration), auto-injectors and prefilled syringes allow for home ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.70% during the forecast ...

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. For full indications and important safety information ...

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. The company noted that the new prefilled syringe reduces the ...

Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a prefilled syringe version of Vyvgart—also known as efgartigimod ...

Cosentyx (secukinumab) may be safe to use while pregnant or breastfeeding. Before starting treatment, you and your doctor can discuss the risks and benefits of Cosentyx treatment during pregnancy ...